PROVAX

Welcome to the Brand page for “PROVAX”, which is offered here for Pharmaceutical compositions for use in immunotherapy comprising adjuvant-antigen formulations, prophylactic and therapeutic vaccines for the treatment of cancer, autoimmune disorders, and infectious diseases in humans;.

Its status is currently believed to be active. Its class is unavailable. “PROVAX” is believed to be currently owned by “Idec Pharmaceuticals Corporation”.